CoChat

The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease

Open access
Kotlyarova, Anna, Iskrina, Aleksandra, Kotlyarov, Stanislav · 2026 · International journal of molecular sciences

The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index; 120 of the 173 sources its claims cite were checked for support.

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is the most common chronic liver disease in the world. The disease progresses from steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The modern concept of "multiple parallel hits" interprets disease progression as the result of the synergistic action of lipotoxicity, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, proinflammatory signals, and gut-liver axis dysfunction. Against the background of the limited translation of preclinical data from animal models due to interspecies differences, the importance of human-oriented in vitro platforms compatible with controlled design and high-throughput screening is increasing. The current review analyzes MASLD models based on the HepG2 cell line, systematizing steatosis induction protocols, evaluating the metabolic characteristics and limitations of this cell, and comparing 2D monocultures, 3D systems, and co-cultures. HepG2 has been shown to demonstrate a predictable steatogenic response to free fatty acids (FFAs) and is convenient for reproducing early stages of pathogenesis and primary pharmacological selection of compounds. At the same time, key limitations of the model are highlighted, namely tumor origin, glycolytic shift (Warburg effect), reduced β-oxidation, impaired very-low-density lipoprotein (VLDL) assembly and secretion, and sharply reduced cytochrome P450 (CYP450) activity, as well as limited reproducibility of fructose-induced de novo lipogenesis (DNL). Comparative analysis demonstrates an increase in physiological relevance with the transition from 2D to 3D and multicomponent co-cultures, accompanied by increased complexity and cost, but allowing for the modeling of inflammation and fibrogenesis. The review justifies approaches to selecting the appropriate platform based on the specific research task.

Overview

CoChat Summary

## TL;DR

This narrative review argues that HepG2 is a useful but incomplete human in vitro model for MASLD, especially for early hepatocyte-centric events like steatosis, lipotoxicity, ER stress, oxidative stress, and mitochondrial dysfunction. It concludes that model choice should match the research question, with 2D HepG2 best for rapid screening and 3D/co-culture systems better for inflammation, fibrogenesis, and higher physiological relevance.

## Key findings

  • HepG2 shows a predictable steatogenic response to free fatty acids and is widely used for MASLD/NAFLD modeling; the review says 2D monocultures are the most accessible tool for early cell damage and can reproduce lipid accumulation, lipotoxicity, ER stress, oxidative stress, and mitochondrial dysfunction.
  • For 2D HepG2 models, the review identifies OA:PA in a 2:1 ratio at 0.5–1.0 mM for 24 h as the preferred setup for screening anti-steatotic effects, because it balances steatogenesis and viability.
  • In one cited study, a 2:1 OA/PA ratio at 2 mM induced significant lipid accumulation with minimal toxicity, while palmitate alone caused pronounced cytotoxic and apoptotic responses; another cited triculture model using FFAs + glucose + insulin + LPS + TGF-β + BSA reproduced steatosis, oxidative stress, inflammation, and fibrogenesis.
  • The review states that physiological relevance increases from 2D monocultures to 3D models to multicomponent co-cultures, but complexity and cost also rise; 3D organ-on-a-chip platforms are highlighted for simultaneously assessing therapeutic efficacy and toxicity.

## Methods

  • Narrative review of MASLD models based on the HepG2 cell line.
  • The paper synthesizes published experimental protocols and compares modeling approaches across 2D monocultures, 3D systems, and co-cultures/tricultures.
  • Main analysis focuses on steatosis induction conditions, metabolic characteristics and limitations of HepG2, and the physiological relevance of different model formats.

## Limitations

  • Stated in the paper: HepG2 has tumor origin, a glycolytic shift (Warburg effect), reduced β-oxidation, impaired VLDL assembly/secretion, sharply reduced CYP450 activity, and limited reproducibility for fructose-induced de novo lipogenesis.
  • Stated in the paper: 2D HepG2 monocultures lack non-parenchymal liver cells and non-physiological geometry, while 3D models are harder to standardize and can limit access for post-experimental analysis.
  • Evident from the text: this is a narrative review rather than a new experimental study, so its conclusions depend on heterogeneous published studies with differing FFA compositions, exposure times, and readouts.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms27083399

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Hierarchy of HepG2 cell models ranked by increasing physiological relevance for studying MASLD. Level 1 (two-dimensional monoculture) reproduces early cellular changes, including steatosis, lipotoxicity, ER stress, oxidative stress, and mitochondrial dysfunction. Suitable for high-throughput screening. Level 2 (3D models)—spheroids and “organ-on-a-chip” platforms—provides spatial organization and improved cell differentiation and enables long-term assessment of culture and pharmacokinetics. Level 3 (co-culture/triculture) includes stellate liver cells (LX-2) and/or macrophages (THP-1), which allows for the modeling of inflammation, fibrogenesis, and intercellular communication, thereby replicating key features of MASLD progression. Physiological relevance, complexity and cost are indicated by stars: ★★★ high, ★★☆ moderate, ★☆☆ low.
Figure 1 Hierarchy of HepG2 cell models ranked by increasing physiological relevance for studying MASLD. Level 1 (two-dimensional monoculture) reproduces early cellular changes, including steatosis, lipotoxicity, ER stress, oxidative stress, and mitochondrial dysfunction. Suitable for high-throughput screening. Level 2 (3D models)—spheroids and “organ-on-a-chip” platforms—provides spatial organization and improved cell differentiation and enables long-term assessment of culture and pharmacokinetics. Level 3 (co-culture/triculture) includes stellate liver cells (LX-2) and/or macrophages (THP-1), which allows for the modeling of inflammation, fibrogenesis, and intercellular communication, thereby replicating key features of MASLD progression. Physiological relevance, complexity and cost are indicated by stars: ★★★ high, ★★☆ moderate, ★☆☆ low.CC BY · PubMed Central

Verification

Claims the paper makes

65 Valid · 4 Not valid · 11 Not checked · 40 Own results and interpretations

34 more claims · 17 with their cited sources checked

Create a free account to see all 120 claims and to verify the 13 references still open.

See all claims — free account
  • It may state two separate claims as one. 78
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Citations

Cites

Metadata

Authors
Kotlyarova, A., Iskrina, A., & Kotlyarov, S.
Affiliations
  • Department of Pharmacy Management and Economics, Ryazan State Medical University, 390026 Ryazan, Russia
  • Ryazan State Medical University named after Academician I.P. Pavlov (RU)
Corresponding author
Kotlyarov, Stanislav
Venue
International journal of molecular sciences
Publisher
MDPI AG
Published
2026-04-10
Volume
27
Issue
8
Pages
3399
ISSN
1422-0067 (ISSN-L)
OpenAlex
W7153190438
Cited by
10
References
156
Citations by year
2026: 10
FWCI
7.39
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
Russian Science Foundation (25-25-01166)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
HepG2 cells, non-alcoholic fatty liver disease, steatosis, 3D cell culture, co-culture model, free fatty acids, de novo lipogenesis, Warburg effect, mitochondrial dysfunction, oxidative stress, endoplasmic reticulum stress, lipotoxicity, VLDL secretion, cytochrome P450, hepatocellular carcinoma, fibrosis, inflammation, high-throughput screening
MeSH terms
Animals, Fatty Liver, Humans, Models, Biological, Hep G2 Cells, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.